ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global DNA Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-4I12362
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global DNA Vaccines Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028
BUY CHAPTERS

Global DNA Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-4I12362
Report
July 2025
Pages:131
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
GSK
Elanco
Boehringer Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Sanofi
Zoties

DNA Vaccines Market Size

In 2024, the global market size of DNA Vaccines was estimated to be worth US$ 5378 million and is forecast to reach approximately US$ 8975 million by 2031 with a CAGR of 7.7% during the forecast period 2025-2031.

DNA Vaccines Market

DNA Vaccines Market

The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.
Global direct-to-consumer genetic testing main players include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc., totally accounting for about 50% of the market. North America is the largest market, with a share over 95%. As for the types of products, it can be divided into recombinant protein vaccine and gene-based vaccine. The most common product is recombinant protein, with a share over 95%. In terms of applications, it is widely used in human and animal. Human is the largest application, holding a share over 95%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for DNA Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Vaccines.
The DNA Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global DNA Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DNA Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of DNA Vaccines Market Report

Report Metric Details
Report Name DNA Vaccines Market
CAGR 7.7%
Segment by Type
  • Recombinant Protein Vaccine
  • Gene-Based Vaccine
Segment by Application
  • Human
  • Animal
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals, Plumbline Life Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of DNA Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of DNA Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, DNA Vaccines sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Merck, GSK, Sanofi, Zoties, Elanco, Boehringer Ingelheim, Indian Immunologicals, Plumbline Life Sciences share in DNA Vaccines Market?

Ans: Global direct-to-consumer genetic testing main players include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc., totally accounting for about 50% of the market.

What is the DNA Vaccines Market share by region?

Ans: North America is the largest market, with a share over 95%.

What is the DNA Vaccines Market share by application?

Ans: Human is the largest application, holding a share over 95%.

Who are the main players in the DNA Vaccines Market report?

Ans: The main players in the DNA Vaccines Market are Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals, Plumbline Life Sciences

What are the Application segmentation covered in the DNA Vaccines Market report?

Ans: The Applications covered in the DNA Vaccines Market report are Human, Animal

What are the Type segmentation covered in the DNA Vaccines Market report?

Ans: The Types covered in the DNA Vaccines Market report are Recombinant Protein Vaccine, Gene-Based Vaccine

1 Study Coverage
1.1 DNA Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global DNA Vaccines Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Recombinant Protein Vaccine
1.2.3 Gene-Based Vaccine
1.3 Market by Application
1.3.1 Global DNA Vaccines Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Human
1.3.3 Animal
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global DNA Vaccines Market Size Estimates and Forecasts
2.1.1 Global DNA Vaccines Revenue 2020-2031
2.1.2 Global DNA Vaccines Sales 2020-2031
2.2 DNA Vaccines Market Size by Region: 2024 Versus 2031
2.3 DNA Vaccines Sales by Region (2020-2031)
2.3.1 Global DNA Vaccines Sales by Region: 2020-2025
2.3.2 Global DNA Vaccines Sales Forecast by Region (2026-2031)
2.3.3 Global DNA Vaccines Sales Market Share by Region (2020-2031)
2.4 DNA Vaccines Market Estimates and Projections by Region (2026-2031)
2.4.1 Global DNA Vaccines Revenue by Region: 2020-2025
2.4.2 Global DNA Vaccines Revenue Forecast by Region (2026-2031)
2.4.3 Global DNA Vaccines Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global DNA Vaccines Sales by Type (2020-2031)
3.1.1.1 Global DNA Vaccines Sales Volume by Type (2020-2031)
3.1.1.2 Global DNA Vaccines Sales Market Share by Type (2020-2031)
3.1.2 Global DNA Vaccines Revenue by Type (2020-2031)
3.1.2.1 Global DNA Vaccines Revenue by Type (2020-2031)
3.1.2.2 Global DNA Vaccines Revenue Market Share by Type (2020-2031)
3.1.3 DNA Vaccines Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global DNA Vaccines Sales by Application (2020-2031)
3.2.1.1 Global DNA Vaccines Sales Volume by Application (2020-2031)
3.2.1.2 Global DNA Vaccines Sales Market Share by Application (2020-2031)
3.2.2 Global DNA Vaccines Revenue by Application (2020-2031)
3.2.2.1 Global DNA Vaccines Revenue by Application (2020-2031)
3.2.2.2 Global DNA Vaccines Revenue Market Share by Application (2020-2031)
3.2.3 DNA Vaccines Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Recombinant Protein Vaccine of DNA Vaccines Revenue Market Share by Application
3.3.2 Gene-Based Vaccine of DNA Vaccines Revenue Market Share by Application
4 Global DNA Vaccines by Manufacturers
4.1 Global Top DNA Vaccines Manufacturers by Sales (2020-2025)
4.1.1 Global DNA Vaccines Sales by Manufacturer (2020-2025)
4.1.2 Global DNA Vaccines Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top DNA Vaccines Manufacturers by Revenue (2020-2025)
4.2.1 Global DNA Vaccines Revenue by Manufacturer (2020-2025)
4.2.2 Global DNA Vaccines Revenue Share by Manufacturer (2020-2025)
4.3 Global DNA Vaccines Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key DNA Vaccines Manufacturers Covered: Ranking by Revenue
4.4.2 Global DNA Vaccines Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global DNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global DNA Vaccines Manufacturing Base Distribution, Product Type
4.5.1 DNA Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into DNA Vaccines Market
4.5.3 Manufacturers DNA Vaccines Product Type and Application
4.5.4 Recombinant Protein Vaccine Market Sales of DNA Vaccines by Manufacturer
4.5.5 Gene-Based Vaccine Market Sales of DNA Vaccines by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Merck
5.1.1 Merck Company Information
5.1.2 Merck Description, Business Overview
5.1.3 Merck DNA Vaccines Products Offered
5.1.4 Merck DNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Merck DNA Vaccines Sales by Product in 2024
5.1.6 Merck DNA Vaccines Sales by Application in 2024
5.1.7 Merck DNA Vaccines Sales by Geographic Area in 2024
5.1.8 Merck Recent Developments
5.2 GSK
5.2.1 GSK Company Information
5.2.2 GSK Description, Business Overview
5.2.3 GSK DNA Vaccines Products Offered
5.2.4 GSK DNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.2.5 GSK DNA Vaccines Sales by Product in 2024
5.2.6 GSK DNA Vaccines Sales by Application in 2024
5.2.7 GSK DNA Vaccines Sales by Geographic Area in 2024
5.2.8 GSK Recent Developments
5.3 Sanofi
5.3.1 Sanofi Company Information
5.3.2 Sanofi Description, Business Overview
5.3.3 Sanofi DNA Vaccines Products Offered
5.3.4 Sanofi DNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Sanofi DNA Vaccines Sales by Product in 2024
5.3.6 Sanofi DNA Vaccines Sales by Application in 2024
5.3.7 Sanofi DNA Vaccines Sales by Geographic Area in 2024
5.3.8 Sanofi Recent Developments
5.4 Zoties
5.4.1 Zoties Company Information
5.4.2 Zoties Description, Business Overview
5.4.3 Zoties DNA Vaccines Products Offered
5.4.4 Zoties DNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Zoties DNA Vaccines Sales by Product in 2024
5.4.6 Zoties DNA Vaccines Sales by Application in 2024
5.4.7 Zoties DNA Vaccines Sales by Geographic Area in 2024
5.4.8 Zoties Recent Developments
5.5 Elanco
5.5.1 Elanco Company Information
5.5.2 Elanco Description, Business Overview
5.5.3 Elanco DNA Vaccines Products Offered
5.5.4 Elanco DNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Elanco DNA Vaccines Sales by Product in 2024
5.5.6 Elanco DNA Vaccines Sales by Application in 2024
5.5.7 Elanco DNA Vaccines Sales by Geographic Area in 2024
5.5.8 Elanco Recent Developments
5.6 Boehringer-Ingelheim
5.6.1 Boehringer-Ingelheim Company Information
5.6.2 Boehringer-Ingelheim Description, Business Overview
5.6.3 Boehringer-Ingelheim DNA Vaccines Products Offered
5.6.4 Boehringer-Ingelheim DNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Boehringer-Ingelheim DNA Vaccines Sales by Product in 2024
5.6.6 Boehringer-Ingelheim DNA Vaccines Sales by Application in 2024
5.6.7 Boehringer-Ingelheim DNA Vaccines Sales by Geographic Area in 2024
5.6.8 Boehringer-Ingelheim Recent Developments
5.7 Indian Immunologicals
5.7.1 Indian Immunologicals Company Information
5.7.2 Indian Immunologicals Description, Business Overview
5.7.3 Indian Immunologicals DNA Vaccines Products Offered
5.7.4 Indian Immunologicals DNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Indian Immunologicals DNA Vaccines Sales by Product in 2024
5.7.6 Indian Immunologicals DNA Vaccines Sales by Application in 2024
5.7.7 Indian Immunologicals DNA Vaccines Sales by Geographic Area in 2024
5.7.8 Indian Immunologicals Recent Developments
5.8 Plumbline Life Sciences
5.8.1 Plumbline Life Sciences Company Information
5.8.2 Plumbline Life Sciences Description, Business Overview
5.8.3 Plumbline Life Sciences DNA Vaccines Products Offered
5.8.4 Plumbline Life Sciences DNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Plumbline Life Sciences DNA Vaccines Sales by Product in 2024
5.8.6 Plumbline Life Sciences DNA Vaccines Sales by Application in 2024
5.8.7 Plumbline Life Sciences DNA Vaccines Sales by Geographic Area in 2024
5.8.8 Plumbline Life Sciences Recent Developments
6 North America
6.1 North America DNA Vaccines Market Size YoY Growth 2020-2031
6.2 North America DNA Vaccines Market Facts & Figures by Country
6.2.1 North America DNA Vaccines Sales by Country (2020-2031)
6.2.2 North America DNA Vaccines Revenue by Country (2020-2031)
6.3 North America DNA Vaccines Sales by Type (2020-2025)
6.4 North America DNA Vaccines Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific DNA Vaccines Market Size YoY Growth 2020-2031
7.2 Asia-Pacific DNA Vaccines Market Facts & Figures by Region
7.2.1 Asia-Pacific DNA Vaccines Sales by Region (2020-2031)
7.2.2 Asia-Pacific DNA Vaccines Revenue by Region (2020-2031)
7.3 Asia-Pacific DNA Vaccines Sales by Type (2020-2025)
7.4 Asia-Pacific DNA Vaccines Sales by Application (2020-2025)
8 Europe
8.1 Europe DNA Vaccines Market Size YoY Growth 2020-2031
8.2 Europe DNA Vaccines Market Facts & Figures by Country
8.2.1 Europe DNA Vaccines Sales by Country (2020-2031)
8.2.2 Europe DNA Vaccines Revenue by Country (2020-2031)
8.3 Europe DNA Vaccines Sales by Type (2020-2025)
8.4 Europe DNA Vaccines Sales by Application (2020-2025)
9 Latin America
9.1 Latin America DNA Vaccines Market Size YoY Growth 2020-2031
9.2 Latin America DNA Vaccines Market Facts & Figures by Country
9.2.1 Latin America DNA Vaccines Sales by Country (2020-2031)
9.2.2 Latin America DNA Vaccines Revenue by Country (2020-2031)
9.3 Latin America DNA Vaccines Sales by Type (2020-2025)
9.4 Latin America DNA Vaccines Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America DNA Vaccines Market Size YoY Growth 2020-2031
10.2 Middle East and Africa DNA Vaccines Market Facts & Figures by Country
10.2.1 Middle East and Africa DNA Vaccines Sales by Country (2020-2031)
10.2.2 Middle East and Africa DNA Vaccines Revenue by Country (2020-2031)
10.3 Middle East and Africa DNA Vaccines Sales by Type (2020-2025)
10.4 Middle East and Africa DNA Vaccines Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 DNA Vaccines Supply Chain Analysis
11.2 DNA Vaccines Key Raw Materials and Upstream Suppliers
11.3 DNA Vaccines Clients Analysis
11.4 DNA Vaccines Sales Channel and Sales Model Analysis
11.4.1 DNA Vaccines Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 DNA Vaccines Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 DNA Vaccines Distributors
12 DNA Vaccines Market Dynamics
12.1 DNA Vaccines Industry Trends
12.2 DNA Vaccines Market Drivers
12.3 DNA Vaccines Market Challenges
12.4 DNA Vaccines Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Merck
GSK
Elanco
Boehringer Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Sanofi
Zoties
List of Tables
 Table 1. Global DNA Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global DNA Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global DNA Vaccines Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global DNA Vaccines Sales by Region (2020-2025) & (K Units)
 Table 5. Global DNA Vaccines Sales Forecast by Region (2026-2031) & (K Units)
 Table 6. Global DNA Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global DNA Vaccines Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global DNA Vaccines Sales Volume by Type (2020-2025) & (K Units)
 Table 9. Global DNA Vaccines Sales Volume by Type (2026-2031) & (K Units)
 Table 10. Global DNA Vaccines Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global DNA Vaccines Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global DNA Vaccines Sales Volume by Application (2020-2025) & (K Units)
 Table 13. Global DNA Vaccines Sales Volume by Application (2026-2031) & (K Units)
 Table 14. Global DNA Vaccines Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global DNA Vaccines Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global DNA Vaccines Sales by Manufacturer (2020-2025) & (K Units)
 Table 17. Global DNA Vaccines Sales Share by Manufacturer (2020-2025)
 Table 18. DNA Vaccines Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. DNA Vaccines Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers DNA Vaccines Price (2020-2025) & (USD/Unit)
 Table 21. Ranking of Global Top DNA Vaccines Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global DNA Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global DNA Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Vaccines as of 2024)
 Table 24. DNA Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into DNA Vaccines Market
 Table 26. Manufacturers DNA Vaccines Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Merck Company Information
 Table 29. Merck Description and Business Overview
 Table 30. Merck DNA Vaccines Product
 Table 31. Merck DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 32. Merck Sales Proportion of DNA Vaccines by Product in 2024
 Table 33. Merck Sales Proportion of DNA Vaccines by Application in 2024
 Table 34. Merck Sales Proportion of DNA Vaccines by Geographic Area in 2024
 Table 35. Merck Recent Developments
 Table 36. GSK Company Information
 Table 37. GSK Description and Business Overview
 Table 38. GSK DNA Vaccines Product
 Table 39. GSK DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 40. GSK Sales Proportion of DNA Vaccines by Product in 2024
 Table 41. GSK Sales Proportion of DNA Vaccines by Application in 2024
 Table 42. GSK Sales Proportion of DNA Vaccines by Geographic Area in 2024
 Table 43. GSK Recent Developments
 Table 44. Sanofi Company Information
 Table 45. Sanofi Description and Business Overview
 Table 46. Sanofi DNA Vaccines Product
 Table 47. Sanofi DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 48. Sanofi Sales Proportion of DNA Vaccines by Product in 2024
 Table 49. Sanofi Sales Proportion of DNA Vaccines by Application in 2024
 Table 50. Sanofi Sales Proportion of DNA Vaccines by Geographic Area in 2024
 Table 51. Sanofi Recent Developments
 Table 52. Zoties Company Information
 Table 53. Zoties Description and Business Overview
 Table 54. Zoties DNA Vaccines Product
 Table 55. Zoties DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 56. Zoties Sales Proportion of DNA Vaccines by Product in 2024
 Table 57. Zoties Sales Proportion of DNA Vaccines by Application in 2024
 Table 58. Zoties Sales Proportion of DNA Vaccines by Geographic Area in 2024
 Table 59. Zoties Recent Developments
 Table 60. Elanco Company Information
 Table 61. Elanco Description and Business Overview
 Table 62. Elanco DNA Vaccines Product
 Table 63. Elanco DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 64. Elanco Sales Proportion of DNA Vaccines by Product in 2024
 Table 65. Elanco Sales Proportion of DNA Vaccines by Application in 2024
 Table 66. Elanco Sales Proportion of DNA Vaccines by Geographic Area in 2024
 Table 67. Elanco Recent Developments
 Table 68. Boehringer-Ingelheim Company Information
 Table 69. Boehringer-Ingelheim Description and Business Overview
 Table 70. Boehringer-Ingelheim DNA Vaccines Product
 Table 71. Boehringer-Ingelheim DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 72. Boehringer-Ingelheim Sales Proportion of DNA Vaccines by Product in 2024
 Table 73. Boehringer-Ingelheim Sales Proportion of DNA Vaccines by Application in 2024
 Table 74. Boehringer-Ingelheim Sales Proportion of DNA Vaccines by Geographic Area in 2024
 Table 75. Boehringer-Ingelheim Recent Developments
 Table 76. Indian Immunologicals Company Information
 Table 77. Indian Immunologicals Description and Business Overview
 Table 78. Indian Immunologicals DNA Vaccines Product
 Table 79. Indian Immunologicals DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 80. Indian Immunologicals Sales Proportion of DNA Vaccines by Product in 2024
 Table 81. Indian Immunologicals Sales Proportion of DNA Vaccines by Application in 2024
 Table 82. Indian Immunologicals Sales Proportion of DNA Vaccines by Geographic Area in 2024
 Table 83. Indian Immunologicals Recent Developments
 Table 84. Plumbline Life Sciences Company Information
 Table 85. Plumbline Life Sciences Description and Business Overview
 Table 86. Plumbline Life Sciences DNA Vaccines Product
 Table 87. Plumbline Life Sciences DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Plumbline Life Sciences Sales Proportion of DNA Vaccines by Product in 2024
 Table 89. Plumbline Life Sciences Sales Proportion of DNA Vaccines by Application in 2024
 Table 90. Plumbline Life Sciences Sales Proportion of DNA Vaccines by Geographic Area in 2024
 Table 91. Plumbline Life Sciences Recent Developments
 Table 92. North America DNA Vaccines Sales by Country (2020-2025) & (K Units)
 Table 93. North America DNA Vaccines Sales by Country (2026-2031) & (K Units)
 Table 94. North America DNA Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 95. North America DNA Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 96. North America DNA Vaccines Sales by Type (2020-2025) & (K Units)
 Table 97. North America DNA Vaccines Sales by Application (2020-2025) & (K Units)
 Table 98. Asia-Pacific DNA Vaccines Sales by Region (2020-2025) & (K Units)
 Table 99. Asia-Pacific DNA Vaccines Sales by Region (2026-2031) & (K Units)
 Table 100. Asia-Pacific DNA Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 101. Asia-Pacific DNA Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 102. Asia-Pacific DNA Vaccines Sales by Type (2020-2025) & (K Units)
 Table 103. Asia-Pacific DNA Vaccines Sales by Application (2020-2025) & (K Units)
 Table 104. Europe DNA Vaccines Sales by Country (2020-2025) & (K Units)
 Table 105. Europe DNA Vaccines Sales by Country (2026-2031) & (K Units)
 Table 106. Europe DNA Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 107. Europe DNA Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 108. Europe DNA Vaccines Sales by Type (2020-2025) & (K Units)
 Table 109. Europe DNA Vaccines Sales by Application (2020-2025) & (K Units)
 Table 110. Latin America DNA Vaccines Sales by Country (2020-2025) & (K Units)
 Table 111. Latin America DNA Vaccines Sales by Country (2026-2031) & (K Units)
 Table 112. Latin America DNA Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 113. Latin America DNA Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 114. Latin America DNA Vaccines Sales by Type (2020-2025) & (K Units)
 Table 115. Latin America DNA Vaccines Sales by Application (2020-2025) & (K Units)
 Table 116. Middle East and Africa DNA Vaccines Sales by Country (2020-2025) & (K Units)
 Table 117. Middle East and Africa DNA Vaccines Sales by Country (2026-2031) & (K Units)
 Table 118. Middle East and Africa DNA Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 119. Middle East and Africa DNA Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 120. Middle East and Africa DNA Vaccines Sales by Type (2020-2025) & (K Units)
 Table 121. Middle East and Africa DNA Vaccines Sales by Application (2020-2025) & (K Units)
 Table 122. DNA Vaccines Key Raw Materials, Industry Status and Trend
 Table 123. DNA Vaccines Key Raw Materials and Upstream Suppliers
 Table 124. DNA Vaccines Clients Status and Trend
 Table 125. DNA Vaccines Typical Clients
 Table 126. DNA Vaccines Distributors
 Table 127. DNA Vaccines Market Trends
 Table 128. DNA Vaccines Market Drivers
 Table 129. DNA Vaccines Market Challenges
 Table 130. DNA Vaccines Market Restraints
 Table 131. Research Programs/Design for This Report
 Table 132. Key Data Information from Secondary Sources
 Table 133. Key Data Information from Primary Sources
 Table 134. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. DNA Vaccines Product Picture
 Figure 2. Global DNA Vaccines Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global DNA Vaccines Sales Market Share by Type in 2024 & 2031
 Figure 4. Recombinant Protein Vaccine Product Picture
 Figure 5. Gene-Based Vaccine Product Picture
 Figure 6. Global DNA Vaccines Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global DNA Vaccines Sales Market Share by Application in 2024 & 2031
 Figure 8. Human
 Figure 9. Animal
 Figure 10. DNA Vaccines Report Years Considered
 Figure 11. Global DNA Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global DNA Vaccines Market Size 2020-2031 (US$ Million)
 Figure 13. Global DNA Vaccines Sales 2020-2031 (K Units)
 Figure 14. Global DNA Vaccines Sales Market Share Forecast by Region (2020-2031)
 Figure 15. Global DNA Vaccines Revenue Market Share by Region (2020-2031)
 Figure 16. Global DNA Vaccines Sales Market Share Forecast by Type (2020-2031)
 Figure 17. Global DNA Vaccines Revenue Market Share Forecast by Type (2020-2031)
 Figure 18. DNA Vaccines Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
 Figure 19. Global DNA Vaccines Sales Market Share Forecast by Application (2020-2031)
 Figure 20. Global DNA Vaccines Revenue Market Share Forecast by Application (2020-2031)
 Figure 21. DNA Vaccines Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
 Figure 22. Recombinant Protein Vaccine of DNA Vaccines Revenue Market Share by Application, 2024 VS 2031
 Figure 23. Gene-Based Vaccine of DNA Vaccines Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Global DNA Vaccines Sales Share by Manufacturer in 2024
 Figure 25. DNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Recombinant Protein Vaccine Market Sales Proportion by Manufacturer in 2024
 Figure 27. Gene-Based Vaccine Market Sales Proportion by Manufacturer in 2024
 Figure 28. North America DNA Vaccines Revenue 2020-2031 (US$ Million)
 Figure 29. North America DNA Vaccines Sales Market Share by Type (2020-2025)
 Figure 30. North America DNA Vaccines Sales Market Share by Application (2020-2025)
 Figure 31. Asia-Pacific DNA Vaccines Revenue 2020-2031 (US$ Million)
 Figure 32. Asia-Pacific DNA Vaccines Sales Market Share by Region (2020-2031)
 Figure 33. Asia-Pacific DNA Vaccines Revenue Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific DNA Vaccines Sales Market Share by Type (2020-2025)
 Figure 35. Asia-Pacific DNA Vaccines Sales Market Share by Application (2020-2025)
 Figure 36. Europe DNA Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 37. Europe DNA Vaccines Sales Market Share by Country (2020-2031)
 Figure 38. Europe DNA Vaccines Revenue Market Share by Country (2020-2031)
 Figure 39. Europe DNA Vaccines Sales Market Share by Type (2020-2025)
 Figure 40. Europe DNA Vaccines Sales Market Share by Application (2020-2025)
 Figure 41. Latin America DNA Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Latin America DNA Vaccines Sales Market Share by Country (2020-2031)
 Figure 43. Latin America DNA Vaccines Revenue Market Share by Country (2020-2025)
 Figure 44. Latin America DNA Vaccines Sales Market Share by Type (2020-2025)
 Figure 45. Latin America DNA Vaccines Sales Market Share by Application (2020-2025)
 Figure 46. Middle East and Africa DNA Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 47. Middle East and Africa DNA Vaccines Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa DNA Vaccines Revenue Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa DNA Vaccines Sales Market Share by Type (2020-2025)
 Figure 50. Middle East and Africa DNA Vaccines Sales Market Share by Application (2020-2025)
 Figure 51. DNA Vaccines Supply Chain (Upstream and Downstream Market)
 Figure 52. Global Production Market Share of DNA Vaccines Raw Materials by Region in 2024
 Figure 53. DNA Vaccines Distribution Channels
 Figure 54. Global DNA Vaccines Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 55. Global DNA Vaccines Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Recombinant DNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global DNA Vaccination Market Research Report 2024
Global Nucleic Vaccine Market Insights Forecast to 2030
Global Human DNA Vaccines Market Insights Forecast to 2030
Global Pet DNA Vaccines Market Research Report 2025
Global Genetic Vaccine Market Insights Forecast to 2030
Global Nucleic Acid Vaccine Market Insights Forecast to 2030
Global Recombinant Protein Vaccine Market Insights Forecast to 2030
Global Recombinant Vector Vaccines Market Insights Forecast to 2030
Global RNA Vaccines Market Insights Forecast to 2030
Global Plasmid DNA Manufacturing Market Insights Forecast to 2030
Recombinant Peptide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
COVID 19 DNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Veterinary Biological Vaccines Market Research Report 2025
Global Animal Vaccines Market Insights Forecast to 2030
Global Pet Recombinant Vaccine Market Research Report 2025
Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2025
Global Recombinant Influenza Vaccine Market Research Report 2024
Global DNA and Gene Chips Market Insights Forecast to 2030
Global Biopharmaceutical and Vaccine Production Market Insights Forecast to 2030

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions